Clinical OMICS

MAR-APR 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/958440

Contents of this Issue

Navigation

Page 38 of 51

June 11 - 13, 2018 • Westin Boston Waterfront • Boston, MA The Leading Annual Meeting Where Big Pharma and Biotech Drive Innovation and Collaboration in Biomarkers, Diagnostics, and Immunotherapy WORLD CONGRESS 2018 BIOMARKERS & IMMUNO-ONCOLOGY C A M B R I D G E H E A LT H T E C H I N S T I T U T E ' S 1 4 t h A N N U A L DISTINGUISHED SPEAKERS Register online using keycode COM18 and receive 15% off any current registration rate June 11 - 12 Immuno-Oncology Biomarkers 1: Predictive Biomarkers and Companion Diagnostics Combination Immunotherapy Clinical and Translational Biomarkers Digital Biomarkers: Biosensors, Wearables, and mHealth June 12 - 13 Immuno-Oncology Biomarkers 2: Immune Profiling and Immune Monitoring Intrinsic and Acquired Resistance to Immunotherapy Biomarkers for Patient Selection IMMUNO-ONCOLOGY BIOMARKERS Now in Boston! BiomarkerWorldCongress.com #BiomarkerIO PREMIER SPONSOR Roy D. Baynes SVP and Chief Medical Officer Merck J. Carl Barrett VP, Oncology Translational Sciences AstraZeneca Robert A. Anders Co-Director, Tumor Microenvironment Center Johns Hopkins University Stefan J. Scherer VP & Head, Early Development Novartis George Poste Chief Scientist, Complex Adaptive Systems Arizona State University George A. Green, IV Head, Pharmacodiagnostics Bristol-Myers Squibb Arnold B. Gelb, MD MS, FASCP, FCAP, Advisor, Companion Diagnostic Development Christopher M. Hartshorn Director, Cancer Treatment and Diagnosis NCI, NIH Shirin Khambata Ford Global Head, Biomarkers and Diagnostics Merck Daniel Karlin Head, Experimental Medicine Pfizer Cecilia Schott VP, Precision Medicine AstraZeneca Mark E. Curran VP and Head, Companion Diagnostics Janssen Immunology Christian Gossens Global Head, Early Development Roche Marc Ladanyii Chair, Molecular Oncology & Diagnostics Memorial loan-Kettering Fred Ramsdell VP, Research Parker Inst. for Cancer Immunotherapy

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAR-APR 2018